SIRT2 regulates LPS-induced renal tubular CXCL2 and CCL2 expression

Journal of the American Society of Nephrology

Volumn 26, Issue 7, 2015, Pages 1549-1560

  Jung, Yu Jin ^a   Lee, Ae Sin ^a   Nguyen Thanh, Tung ^a   Kim, Dal ^a   Kang, Kyung Pyo ^a,b   Lee, Sik ^a,b   Park, Sung Kwang ^a,b   Kim, Won ^a,b  

^a Chonbuk National University Medical School   (South Korea)

^b Jeonbuk National University Medical School and Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SIRTUIN 2; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CCL2 PROTEIN, MOUSE; CXCL2 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DISORDER; KIDNEY TUBULE EPITHELIUM; MACROPHAGE; MOUSE; NEPHRITIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; EPITHELIUM CELL; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; POLYMERASE CHAIN REACTION; PROCEDURES; RANDOMIZATION;

ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CXCL2; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES, PROXIMAL; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; POLYMERASE CHAIN REACTION; RANDOM ALLOCATION; SIRTUIN 2;

EID: 84934766843     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014030226     Document Type: Article

References (34)

1. Yamamoto H, Schoonjans K, Auwerx J: Sirtuin functions in health and disease. Mol Endocrinol 21: 1745-1755, 2007
2. KimDH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, HanMK, Lee SY, Ramkumar KM, Sung MJ, Kim W: SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol 301: F427-F435, 2011
3. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23: 2369-2380, 2004
4. GiannakouME, Partridge L: The interaction between FOXO and SIRT1: Tipping the balance towards survival. Trends Cell Biol 14: 408-412, 2004
5. FinninMS,Donigian JR, PavletichNP: Structure of the histone deacetylase SIRT2. Nat Struct Biol 8: 621-625, 2001
6. Kim HS, Vassilopoulos A, Wang RH, Lahusen T, Xiao Z, Xu X, Li C, Veenstra TD, Li B, Yu H, Ji J, Wang XW, Park SH, Cha YI, Gius D, Deng CX: SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell 20: 487-499, 2011
7. Serrano L, Martínez-Redondo P, Marazuela-Duque A, Vazquez BN, Dooley SJ, Voigt P, Beck DB, Kane-Goldsmith N, Tong Q, Rabanal RM, Fondevila D, Muñoz P, Krüger M, Tischfield JA, Vaquero A: The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation. Genes Dev 27: 639-653, 2013
8. Eskandarian HA, Impens F, Nahori MA, Soubigou G, Coppée JY, Cossart P, Hamon MA: A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection. Science 341: 1238858, 2013
9. KimMJ, KimDW, Park JH, Kim SJ, Lee CH, Yong JI, Ryu EJ, Cho SB, Yeo HJ, Hyeon J, Cho SW, KimDS, SonO, Park J, Han KH, Cho YS, EumWS, Choi SY: PEP-1-SIRT2 inhibits inflammatory response and oxidative stress-induced cell death via expression of antioxidant enzymes in murine macrophages. Free Radic Biol Med 63: 432-445, 2013
10. Pais TF, Szego EM, Marques O, Miller-Fleming L, Antas P, Guerreiro P, de Oliveira RM, Kasapoglu B, Outeiro TF: The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J 32: 2603-2616, 2013
11. Galliera E, Corsi MM, Bonecchi R, Locati M, Mantovani A: Chemokines as pharmacological targets. Mini Rev Med Chem 8: 638-646, 2008
12. Chung AC, Lan HY: Chemokines in renal injury. J Am Soc Nephrol 22: 802-809, 2011
13. Miura M, Fu X, Zhang QW, Remick DG, Fairchild RL: Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol 159: 2137-2145, 2001
14. Roche JK, Keepers TR, Gross LK, Seaner RM,Obrig TG: CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation. Am J Pathol 170: 526-537, 2007
15. De Filippo K,Dudeck A, HasenbergM,Nye E, van Rooijen N, Hartmann K, Gunzer M, Roers A, Hogg N:Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121: 4930-4937, 2013
16. Anders HJ, Vielhauer V, Schlöndorff D: Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63: 401-415, 2003
17. Keyse SM: Protein phosphatases and the regulation of MAP kinase activity. Semin Cell Dev Biol 9: 143-152, 1998
18. Camps M, Nichols A, Arkinstall S: Dual specificity phosphatases: A gene family for control of MAP kinase function. FASEB J 14: 6-16, 2000
19. Cao W, Bao C, Padalko E, Lowenstein CJ: Acetylation of mitogenactivated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J ExpMed 205: 1491-1503, 2008
20. Kang KP, Kim DH, Jung YJ, Lee AS, Lee S, Lee SY, Jang KY, Sung MJ, Park SK, Kim W: Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation. Nephrol Dial Transplant 24: 3012-3020, 2009
21. Kobayashi Y: Neutrophil infiltration and chemokines. Crit Rev Immunol 26: 307-316, 2006
22. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM, Flavell RA: Dynamic regulation of pro-and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. ProcNatl Acad Sci U S A 103: 2274-2279, 2006
23. Chi H, Flavell RA: Acetylation ofMKP-1 and the control of inflammation. Sci Signal 1: pe44, 2008
24. Ha J, Lee Y, Kim HH: CXCL2 mediates lipopolysaccharide-induced osteoclastogenesis in RANKL-primed precursors. Cytokine 55: 48-55, 2011
25. Winterberg PD, Wang Y, Lin KM, Hartono JR, Nagami GT, Zhou XJ, Shelton JM, Richardson JA, Lu CY: Reactive oxygen species and IRF1 stimulate IFNa production by proximal tubules during ischemic AKI. Am J Physiol Renal Physiol 305: F164-F172, 2013
26. Lemay S, Rabb H, Postler G, Singh AK: Prominent and sustained upregulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation 69: 959-963, 2000
27. Ranganathan P, Jayakumar C, Manicassamy S, Ramesh G: CXCR2 knockout mice are protected against DSS-colitis-induced acute kidney injury and inflammation.AmJ Physiol Renal Physiol 305: F1422-F1427, 2013
28. Lee AS, KimDH, Lee JE, Jung YJ, Kang KP, Lee S, Park SK, Kwak JY, Lee SY, Lim ST, Sung MJ, Yoon SR, Kim W: Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis. Cancer Res 71: 4506-4517, 2011
29. Kwon TH, Frøkiærx J, Nielsenx S: Regulation of aquaporin-2 in the kidney: A molecular mechanism of body-water homeostasis. Kidney Res Clin Pract 32: 96-102, 2013
30. Schnermann J, Huang Y, Mizel D: Fluid reabsorption in proximal convoluted tubules of mice with gene deletions of claudin-2 and/or aquaporin1. Am J Physiol Renal Physiol 305: F1352-F1364, 2013
31. Lee AS, Lee JE, Jung YJ, KimDH, Kang KP, Lee S, Park SK, Lee SY, Kang MJ, Moon WS, Kim HJ, Jeong YB, Sung MJ, Kim W: Vascular endothelial growth factor-C and-D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. Kidney Int 83: 50-62, 2013
32. Kim SH, Jung YJ, Lee S, Park SK, Lee JH, Kim NH, Kim W: Decreased serum level and increased urinary excretion of vascular endothelial growth factor-C in patients with chronic kidney disease. Kidney ResClin Pract 32: 66-71, 2013
33. Kim DH, Jung YJ, Lee AS, Lee S, Kang KP, Lee TH, Lee SY, Jang KY, Moon WS, Choi KS, Yoon KH, Sung MJ, Park SK, Kim W: COMPangiopoietin-1 decreases lipopolysaccharide-induced acute kidney injury. Kidney Int 76: 1180-1191, 2009
34. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M, Moore PK: Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 19: 1196-1198, 2005